Innova Captab Ltd. benchmarking: Performance to industry peers

Financial

	Innova Captab	Sun Pharma Adv. Res	Suven Life Sciences
Operational Metrics
Financials
5 yr Average ROE	20.73 %	52.63 %	0.0
5yr average Equity Multiplier	2.34	1.39	1.55
5yr Average Asset Turnover Ratio	1.03	0.22	0.05
5yr Avg Net Profit Margin	8.55 %	-361.01 %	-1150.51 %
Price to Book	4.59	0.0	9.36
P/E	35.54	0.0	0.0
5yr Avg Cash Conversion Cycle	31.3 Days	80.33 Days	97.84 Days
Inventory Days	52.34 Days	0.0	10.88 Days
Days Receivable	89.43 Days	80.33 Days	71.91 Days
Days Payable	105.42 Days	0.0	0.0
5yr Average Interest Coverage Ratio	22.73	-97.45	-373.47
5yr Avg ROCE	21.99 %	208.61 %	-82.34 %
5yr Avg Operating Profit Margin	13.36 %	-357.39 %	-1227.3 %
5 yr average Debt to Equity	0.55	-0.27	0.0
5yr CAGR Net Profit	30.09 %	9.0 %	17.38 %
5yr Average Return on Assets	8.63 %	-68.32 %	-54.63 %
Shareholdings
Promoter Holding	50.9 %	65.67 %	70.15 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-0.01 %	0.58 %
Change in Mutual Fund Holding (3 Yrs)	7.1 %	0.64 %	1.78 %

	Innova Captab	Sun Pharma Adv. Res	Suven Life Sciences
Product Wise Break-Up	Product Wise Break-Up Drugs and pharmaceutical products 100.0 R&D Services 0 Research and Development 0 Services (DDDSS) 0 Manufacturing (CRAMS) 0	Product Wise Break-Up Drugs and pharmaceutical products 0 Manufacturing (CRAMS) 0 Research and Development 100.0 Services (DDDSS) 0 Research and Development 0	Product Wise Break-Up Drugs and pharmaceutical products 0 Manufacturing (CRAMS) 0 R&D Services 0 Services (DDDSS) 0 Research and Development 100.0
Segment Break-Up	Segment Break-Up CDMO 70.3 Branded Generics 29.7 Sharon Bio Medicine 0	-	-
Location Wise Break-Up	Location Wise Break-Up India 72.0 Rest of the World 0 Europe 0 USA 0 Others 28.0	Location Wise Break-Up Rest of the World 2.35 USA 0 Europe 0 India 97.65	Location Wise Break-Up Rest of the World 0 USA 0.95 Europe 5.24 India 71.08 Others 22.73